Effectiveness of the 2023 Autumn XBB.1.5 COVID‐19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study

XBB.1.5 vaccination provided minimal residual protection against severe COVID-19 outcomes among adults aged ≥ 65 years more than 6 months after vaccination, during the summer 2024 period of increased SARS-CoV-2 activity.

Authors

Institutions

Publication Details

Journal
Influenza and Other Respiratory Viruses
Published
2025-11-28
DOI
https://doi.org/10.1111/irv.70198
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effectiveness of the 2023 Autumn XBB.1.5 COVID‐19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study

James Humphreys, Toon Braeye, Ida Rask Moustsen‐Helms, Esther Kissling et al.
Influenza and Other Respiratory Viruses
SARS-CoV-2 and COVID-19 Research
article

Effectiveness of the 2023 Autumn XBB.1.5 COVID‐19 Booster During Summer 2024 in the EU/EEA: A VEBIS Electronic Health Record Network Study

James Humphreys, Toon Braeye, Ida Rask Moustsen‐Helms, Esther Kissling, Susana Monge, Nicklas Pihlström, Izaak Van Evercooren, Massimo Fabiani, Sabrina Bacci, Ausenda Machado, Nathalie Nicolay, Chiara Sacco, Christian Holm Hansen, Anthony Nardone, Patrícia Soares, Rickard Ljung, Iván Martínez‐Baz, Baltazar Nunes
article en

Abstract

XBB.1.5 vaccination provided minimal residual protection against severe COVID-19 outcomes among adults aged ≥ 65 years more than 6 months after vaccination, during the summer 2024 period of increased SARS-CoV-2 activity.

Influenza and Other Respiratory VirusesVol. 19(12)
Statens Serum Institut (DK), Medical Products Agency (SE), Istituto Superiore di Sanità (IT), Instituto de Salud Carlos III (ES), Karolinska Institutet (SE), Instituto de Salud Pública de Navarra (ES), Centre for Biomedical Network Research on Rare Diseases (ES), Instituto Nacional de Saúde (MZ), Sciensano (Belgium) (BE), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES), European Centre for Disease Prevention and Control (SE)
European Centre for Disease Prevention and Control, Fundação para a Ciência e a Tecnologia
Openalex Percentile: Top 56%
SARS-CoV-2 and COVID-19 Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.